no statement of use filed
on 13 Jul 2020
Last Applicant/ Owned by
Lilly Corporate Center
Indianapolis
IN
46285
Serial Number
87240326 filed on 17th Nov 2016
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disordeRead More
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, sleep disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases
No 87240326
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
13th Jul 2020 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
13th Jul 2020 | ABANDONMENT - NO USE STATEMENT FILED |
28th Nov 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
27th Nov 2019 | EXTENSION 5 GRANTED |
22nd Nov 2019 | EXTENSION 5 FILED |
22nd Nov 2019 | TEAS EXTENSION RECEIVED |
19th Nov 2019 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
18th Nov 2019 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
11th May 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
09th May 2019 | EXTENSION 4 FILED |